OTCMKTS:MSLP

MusclePharm - MSLP Stock Forecast, Price & News

$0.0013

0.00 (0.00%)

(As of 01/30/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.0013
▼
$0.0013
50-Day Range: N/A
52-Week Range: $0.0002
▼
$0.0002

Volume: N/A
Average Volume: 26,442 shs
Market Capitalization: $43,407.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About MusclePharm (OTCMKTS:MSLP) Stock

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Stock News Headlines

December 23, 2022 | thestreet.com

Why MusclePharm (MSLP) Stock Is Up Today

July 6, 2022 | finance.yahoo.com

MusclePharm Announces the Launch of FitMiss Energy

January 31, 2023 | Porter & Company (Ad)

The Next Big Crisis Is Here

You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

June 23, 2022 | seekingalpha.com

MusclePharm Files For Uplisting IPO To Nasdaq

June 7, 2022 | seekingalpha.com

MusclePharm announces additional private placement of $2.5M senior secured notes

May 24, 2022 | finance.yahoo.com

MusclePharm to Present at the LD Micro Invitational XII Conference

May 16, 2022 | benzinga.com

MusclePharm Announces First Quarter 2022...

May 16, 2022 | seekingalpha.com

MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call Transcript

January 31, 2023 | UNKNOWN (Ad)

Hot craft spirits opportunity you don't want to miss

Award winning products. Global distribution. New distillery. New products.

May 16, 2022 | finance.yahoo.com

MusclePharm Announces First Quarter 2022 Financial Results

May 5, 2022 | morningstar.com

Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results

April 14, 2022 | finance.yahoo.com

MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results

April 12, 2022 | finance.yahoo.com

MusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022

March 31, 2022 | finance.yahoo.com

MusclePharm Announces Launch into Ready-to-Drink Protein Category

March 11, 2022 | seekingalpha.com

MusclePharm releases preliminary Q421 results

March 11, 2022 | finance.yahoo.com

MusclePharm Announces Preliminary Fourth Quarter and Full Year 2021 Revenue and Begins Fiscal 2022 with Strong First Quarter Guidance

March 2, 2022 | finance.yahoo.com

MusclePharm to Participate at the 34th Annual Roth Conference

February 24, 2022 | finance.yahoo.com

MusclePharm Announces Partnership with Costco for MP Energy Drink in Southern California and Hawaii Regions

February 15, 2022 | seekingalpha.com

MusclePharm teams up with Alliance Sales & Marketing

February 15, 2022 | finance.yahoo.com

MusclePharm Announces National Partnership with Alliance Sales & Marketing for Energy Drink Business

February 7, 2022 | finance.yahoo.com

MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco US

February 2, 2022 | seekingalpha.com

MusclePharm expands distribution channel with Amazon tie-up for energy drink line

February 2, 2022 | finance.yahoo.com

MusclePharm Dramatically Expands Distribution Channel with Amazon.com; Offering Three Flavors of MP Combat Energy Drinks to Its 200 Million Prime Members

November 15, 2021 | finance.yahoo.com

MusclePharm Announces Third Quarter 2021 Financial Results

October 29, 2021 | finance.yahoo.com

MusclePharm adds former Rockstar Energy executive to MP beverage team to lead product development and marketing for two new Performance Energy drinks

October 27, 2021 | finance.yahoo.com

MusclePharm Reports 2014 Fourth-Quarter and Full-Year Financial Results

October 15, 2021 | au.finance.yahoo.com

Global Warming Solutions, Inc. Announces the Appointment of a New Board Member

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Company Calendar

Last Earnings: 8/10/2015
Today: 1/30/2023
Next Earnings (Estimated): 3/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Consumer Staples
Current Symbol: OTCMKTS:MSLP
CUSIP: N/A
CIK: 1415684
Web: www.musclepharm.com
Phone: (800) 292-3909
Fax: N/A
Employees: 27
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.58)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-12,870,000.00
Net Margins: -38.51%
Pretax Margin: -38.52%
Return on Equity: N/A
Return on Assets: -169.56%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.25
Quick Ratio: 0.23

Sales & Book Value

Annual Sales: $50.04 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.94) per share
Price / Book: 0.00

Miscellaneous

Outstanding Shares: 33,390,000
Free Float: 13,121,000
Market Cap: $43,407.00
Optionable: Not Optionable
Beta: -0.07

Key Executives

Mr. Ryan Charles Drexler (Age 51)
Exec. Chairman & CEO
Comp: $1.64M

John Mills Mills
Sr. Managing Director

Mr. Gary Charles Shirshac (Age 60)
Interim Chief Financial Officer

Mr. Eric Chin (Age 42)
Chief Accounting Officer & Director

Dr. Roscoe M. Moore Jr. (Age 77)
DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board

Mr. Mark E. Groussman (Age 49)
Consultant

Key Competitors

View All Competitors

MSLP Stock - Frequently Asked Questions

How have MSLP shares performed in 2023?: MusclePharm's stock was trading at $0.0007 at the beginning of the year. Since then, MSLP stock has increased by 85.7% and is now trading at $0.0013.
View the best growth stocks for 2023 here.
When is MusclePharm's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our MSLP earnings forecast.
How were MusclePharm's earnings last quarter?: MusclePharm Co. (OTCMKTS:MSLP) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The company had revenue of $50.48 million for the quarter, compared to analysts' expectations of $55 million.
What other stocks do shareholders of MusclePharm own?: Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), Avino Silver & Gold Mines (ASM), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY).

What is MusclePharm's stock symbol?: MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."
How do I buy shares of MusclePharm?: Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MusclePharm's stock price today?: One share of MSLP stock can currently be purchased for approximately $0.00.
How much money does MusclePharm make?: MusclePharm (OTCMKTS:MSLP) has a market capitalization of $43,407.00 and generates $50.04 million in revenue each year. The company earns $-12,870,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.
How can I contact MusclePharm?: MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The official website for the company is www.musclepharm.com. The company can be reached via phone at (800) 292-3909 or via email at investors@musclepharm.com.

This page (OTCMKTS:MSLP) was last updated on 1/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial